Abstract IA01: Moving phase 1 trials to first-line metastatic disease: Challenges and Opportunities
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Author: Anna F. Farago
Institution: Amgen (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4415444239
Cites:
Cited by:
Related to:
